89 related articles for article (PubMed ID: 23600219)
1. [The diagnostic value of conventional MRI in the differentiation of malignant tumor from benign lesion in prostatic peripheral zone].
Zhou Y; Zhao S; Bai J; Yang L; Liu RB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 44(1):94-8. PubMed ID: 23600219
[TBL] [Abstract][Full Text] [Related]
2. The value of ESWAN in diagnosis and differential diagnosis of prostate cancer: Preliminary study.
Xin JY; Gao SS; Liu JG; Sun CF; Han Y; Sun XH; Wang XZ; Wang B
Magn Reson Imaging; 2017 Dec; 44():26-31. PubMed ID: 28782677
[TBL] [Abstract][Full Text] [Related]
3. [Application evaluation of multi-parametric MRI in the diagnosis and differential diagnosis of early prostate cancer and prostatitis].
Li P; Huang Y; Li Y; Cai L; Ji GH; Zheng Y; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):2973-2977. PubMed ID: 27760657
[No Abstract] [Full Text] [Related]
4. Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions.
Xu M; Fang M; Zou J; Yang S; Yu D; Zhong L; Hu C; Zang Y; Dong D; Tian J; Fang X
Eur J Radiol; 2019 May; 114():38-44. PubMed ID: 31005174
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
7. [Value of magnetic resonance imaging for early diagnosis of prostatic carcinoma in central zone].
He H; Fan S; Li Y; Ke M; Li Y; Chen B; Yu H
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1051-4. PubMed ID: 24851886
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
Ren J; Huan Y; Wang H; Chang YJ; Zhao HT; Ge YL; Liu Y; Yang Y
Clin Radiol; 2008 Feb; 63(2):153-9. PubMed ID: 18194690
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI.
Niaf E; Rouvière O; Mège-Lechevallier F; Bratan F; Lartizien C
Phys Med Biol; 2012 Jun; 57(12):3833-51. PubMed ID: 22640958
[TBL] [Abstract][Full Text] [Related]
11. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
[TBL] [Abstract][Full Text] [Related]
13. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone.
Li H; Sugimura K; Kaji Y; Kitamura Y; Fujii M; Hara I; Tachibana M
AJR Am J Roentgenol; 2006 Mar; 186(3):729-42. PubMed ID: 16498100
[TBL] [Abstract][Full Text] [Related]
14. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
15. [Magnetic resonance imaging in the diagnosis of prostatic carcinoma and benign hyperplasia].
Fujiwara K; Isaka S; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1336-42. PubMed ID: 2480470
[TBL] [Abstract][Full Text] [Related]
16. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules.
desouza NM; Reinsberg SA; Scurr ED; Brewster JM; Payne GS
Br J Radiol; 2007 Feb; 80(950):90-5. PubMed ID: 17303616
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: computer-aided diagnosis with multiparametric 3-T MR imaging--effect on observer performance.
Hambrock T; Vos PC; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ
Radiology; 2013 Feb; 266(2):521-30. PubMed ID: 23204542
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between benign prostatic hyperplasia and prostate cancer in the transitional zone evaluated by 1H magnetic resonance spectroscopic imaging.
Li SY; Chen M; Wang R; Zhou C
Chin Med Sci J; 2007 Dec; 22(4):238-42. PubMed ID: 18246671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
